Shopping Cart
- Remove All
- Your shopping cart is currently empty
APTSTAT3-9R acetate is a selective peptide binding STAT3 with antiproliferative and antitumor activity. APTSTAT3-9R acetate and inhibits STAT3 activation and downstream signaling by specifically blocking STAT3 phosphorylation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $227 | Backorder | |
5 mg | $677 | Backorder | |
10 mg | $997 | Backorder | |
25 mg | $1,827 | Backorder | |
50 mg | $2,742 | Backorder | |
100 mg | $4,113 | Backorder |
Description | APTSTAT3-9R acetate is a selective peptide binding STAT3 with antiproliferative and antitumor activity. APTSTAT3-9R acetate and inhibits STAT3 activation and downstream signaling by specifically blocking STAT3 phosphorylation. |
In vitro | APTSTAT3-9R acetate (7.5, 15, and 30 μmol/L) significantly reduces STAT3–DNA-binding activity in a dose-dependent manner in human lung carcinoma cells (A549) but does not affect the level of AKT phosphorylation, indicating specificity of the aptide. APTSTAT3-9R acetate (30 μM) suppresses cell viability and proliferation of cancer cells and significantly suppresses colony formation. The IC50s are 10 to 20 μM in A549, B16F1, and HepG2 cells[1]. |
In vivo | In female BALB/c nude mice with A549 cells, APTSTAT3-9R acetate (8 mg/kg in 50 μL; intratumoral injection) suppresses tumor growth[1]. |
Molecular Weight | 5007.56 |
Formula | C225H334N80O53 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.